NCT04197778View on ClinicalTrials.gov

Food Effect Study of DDO-3055 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

January 18, 2020

Study Completion Date

January 18, 2020

Conditions
Anemia in Chronic Kidney Disease
Interventions
DRUG

DDO-3055 tablet

DDO-3055 tablet, 2 single doses separated by 6 days.

Trial Locations (1)

100037

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04197778 - Food Effect Study of DDO-3055 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter